Latest period
$89.89M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$60.30M
Latest annual
$0.00
Stock-Based Compensation history chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: $0.00
Stock-Based Compensation growth chart for IDEXX Laboratories (IDXX) from 1991 to 2025
Latest: -100.0%
Stock-Based Compensation history table for IDEXX Laboratories (IDXX) from 1991 to 2025
| 2025 | $0.00 | -100.0% | −$60.30M | ||
| 2024 | $60.30M | +0.9% | +$556.00K | ||
| 2023 | $59.74M | +20.0% | +$9.97M | ||
| 2022 | $49.77M | +31.8% | +$12.02M | ||
| 2021 | $37.76M | +22.0% | +$6.80M | ||
| 2020 | $30.95M | -21.2% | −$8.33M | ||
| 2019 | $39.28M | +56.1% | +$14.12M | ||
| 2018 | $25.16M | +7.0% | +$1.64M | ||
| 2017 | $23.52M | +18.2% | +$3.63M | ||
| 2016 | $19.89M | +0.0% | +$7.00K | ||
| 2015 | $19.88M | +9.9% | +$1.78M | ||
| 2014 | $18.10M | +9.4% | +$1.56M | ||
| 2013 | $16.54M | +3.7% | +$587.00K | ||
| 2012 | $15.95M | +2.9% | +$456.00K | ||
| 2011 | $15.50M | +16.8% | +$2.23M | ||
| 2010 | $13.26M | +14.1% | +$1.64M | ||
| 2009 | $11.62M | +10.7% | +$1.12M | ||
| 2008 | $10.50M | +19.7% | +$1.73M | ||
| 2007 | $8.78M | -19.1% | −$2.07M | ||
| 2006 | $10.84M | +7931.1% | +$10.71M | ||
| 2005 | $135.00K | 0.0% | $0.00 | ||
| 2004 | $135.00K | -2.2% | −$3.00K | ||
| 2003 | $138.00K | — | +$138.00K | ||
| 2002 | $0.00 | — | $0.00 | ||
| 2001 | $0.00 | — | $0.00 | ||
| 2000 | $0.00 | — | $0.00 | ||
| 1999 | $0.00 | — | $0.00 | ||
| 1998 | $0.00 | — | $0.00 | ||
| 1997 | $0.00 | — | $0.00 | ||
| 1996 | $0.00 | — | $0.00 | ||
| 1995 | $0.00 | — | $0.00 | ||
| 1994 | $0.00 | — | $0.00 | ||
| 1993 | $0.00 | — | $0.00 | ||
| 1992 | $0.00 | — | $0.00 | ||
| 1991 | $0.00 | — | — |
- 2025$0.00-100.0%
- 2024$60.30M+0.9%
- 2023$59.74M+20.0%
- 2022$49.77M+31.8%
- 2021$37.76M+22.0%
- 2020$30.95M-21.2%
- 2019$39.28M+56.1%
- 2018$25.16M+7.0%
- 2017$23.52M+18.2%
- 2016$19.89M+0.0%
- 2015$19.88M+9.9%
- 2014$18.10M+9.4%
- 2013$16.54M+3.7%
- 2012$15.95M+2.9%
- 2011$15.50M+16.8%
- 2010$13.26M+14.1%
- 2009$11.62M+10.7%
- 2008$10.50M+19.7%
- 2007$8.78M-19.1%
- 2006$10.84M+7931.1%
- 2005$135.00K0.0%
- 2004$135.00K-2.2%
- 2003$138.00K—
- 2002$0.00—
- 2001$0.00—
- 2000$0.00—
- 1999$0.00—
- 1998$0.00—
- 1997$0.00—
- 1996$0.00—
- 1995$0.00—
- 1994$0.00—
- 1993$0.00—
- 1992$0.00—
- 1991$0.00—
Stock-Based Compensation values are taken from IDEXX Laboratories's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at IDEXX Laboratories (IDXX)
Stock-Based Compensation for IDEXX Laboratories (IDXX): headline value $89.89M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, IDEXX Laboratories (IDXX) reported stock-based compensation of $0.00 – plunged 100.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, IDEXX Laboratories stock-based compensation compounded at -100.0% per year, with a net decline across the window.
The record annual stock-based compensation stands at $60.30M, reached in 2024; the historical low of $0.00 was recorded in 1991.
IDEXX Laboratories Stock-Based Compensation by Year
IDEXX Laboratories Stock-Based Compensation 2025: $0.00
In 2025, IDEXX Laboratories reported stock-based compensation of $0.00, plunged 100.0% below 2024.
IDEXX Laboratories Stock-Based Compensation 2024: $60.30M
IDEXX Laboratories stock-based compensation in 2024 was $60.30M, edged up 0.9% from 2023. This figure represents the highest annual value in the available history.
IDEXX Laboratories Stock-Based Compensation 2023: $59.74M
2023's stock-based compensation for IDEXX Laboratories came in at $59.74M, grew 20.0% from 2022.
IDEXX Laboratories Stock-Based Compensation 2022: $49.77M
IDEXX Laboratories posted stock-based compensation of $49.77M in 2022, surged 31.8% from 2021.
IDEXX Laboratories Stock-Based Compensation 2021: $37.76M
IDEXX Laboratories stock-based compensation in 2021 was $37.76M.
See more financial history for IDEXX Laboratories (IDXX).
Sector peers by Stock-Based Compensation
Healthcare peers of IDEXX Laboratories (IDXX), ranked by their latest stock-based compensation
| $1.35B | |
| $971.00M | |
| $955.00M | |
| $626.00M | |
| $0.00 | |
| $0.00 | |
| $0.00 | |
| $0.00 |
- $1.35B
- $971.00M
- $955.00M
- $626.00M
- $0.00
- $0.00
- $0.00
- $0.00
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation